Cargando…
Novel Inhibitors of E. coli RecA ATPase Activity
The bacterial RecA protein has been implicated as a bacterial drug target not as an antimicrobial target, but as an adjuvant target with the potential to suppress the mechanism by which bacteria gain drug resistance. In order to identify small molecules that inhibit RecA/ssDNA nucleoprotein filament...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905775/ https://www.ncbi.nlm.nih.gov/pubmed/20648224 http://dx.doi.org/10.2174/1875397301004010034 |
_version_ | 1782183997683531776 |
---|---|
author | Sexton, Jonathan Z Wigle, Tim J He, Qingping Hughes, Mark A Smith, Ginger R Singleton, Scott F Williams, Alfred L Yeh, Li-An |
author_facet | Sexton, Jonathan Z Wigle, Tim J He, Qingping Hughes, Mark A Smith, Ginger R Singleton, Scott F Williams, Alfred L Yeh, Li-An |
author_sort | Sexton, Jonathan Z |
collection | PubMed |
description | The bacterial RecA protein has been implicated as a bacterial drug target not as an antimicrobial target, but as an adjuvant target with the potential to suppress the mechanism by which bacteria gain drug resistance. In order to identify small molecules that inhibit RecA/ssDNA nucleoprotein filament formation, we have adapted the phosphomolybdate-blue ATPase assay for high throughput screening to determine RecA ATPase activity against a library of 33,600 compounds, which is a selected representation of diverse structure of 350,000. Four distinct chemotypes were represented among the 40 validated hits. SAR and further chemical synthesis is underway to optimize this set of inhibitors to be used as antimicrobial adjuvant agents. |
format | Text |
id | pubmed-2905775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-29057752010-07-20 Novel Inhibitors of E. coli RecA ATPase Activity Sexton, Jonathan Z Wigle, Tim J He, Qingping Hughes, Mark A Smith, Ginger R Singleton, Scott F Williams, Alfred L Yeh, Li-An Curr Chem Genomics Article The bacterial RecA protein has been implicated as a bacterial drug target not as an antimicrobial target, but as an adjuvant target with the potential to suppress the mechanism by which bacteria gain drug resistance. In order to identify small molecules that inhibit RecA/ssDNA nucleoprotein filament formation, we have adapted the phosphomolybdate-blue ATPase assay for high throughput screening to determine RecA ATPase activity against a library of 33,600 compounds, which is a selected representation of diverse structure of 350,000. Four distinct chemotypes were represented among the 40 validated hits. SAR and further chemical synthesis is underway to optimize this set of inhibitors to be used as antimicrobial adjuvant agents. Bentham Open 2010-05-26 /pmc/articles/PMC2905775/ /pubmed/20648224 http://dx.doi.org/10.2174/1875397301004010034 Text en © Sexton et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Sexton, Jonathan Z Wigle, Tim J He, Qingping Hughes, Mark A Smith, Ginger R Singleton, Scott F Williams, Alfred L Yeh, Li-An Novel Inhibitors of E. coli RecA ATPase Activity |
title | Novel Inhibitors of E. coli RecA ATPase Activity |
title_full | Novel Inhibitors of E. coli RecA ATPase Activity |
title_fullStr | Novel Inhibitors of E. coli RecA ATPase Activity |
title_full_unstemmed | Novel Inhibitors of E. coli RecA ATPase Activity |
title_short | Novel Inhibitors of E. coli RecA ATPase Activity |
title_sort | novel inhibitors of e. coli reca atpase activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905775/ https://www.ncbi.nlm.nih.gov/pubmed/20648224 http://dx.doi.org/10.2174/1875397301004010034 |
work_keys_str_mv | AT sextonjonathanz novelinhibitorsofecolirecaatpaseactivity AT wigletimj novelinhibitorsofecolirecaatpaseactivity AT heqingping novelinhibitorsofecolirecaatpaseactivity AT hughesmarka novelinhibitorsofecolirecaatpaseactivity AT smithgingerr novelinhibitorsofecolirecaatpaseactivity AT singletonscottf novelinhibitorsofecolirecaatpaseactivity AT williamsalfredl novelinhibitorsofecolirecaatpaseactivity AT yehlian novelinhibitorsofecolirecaatpaseactivity |